Twitter LinkedIn
    Friday, May 20
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Investments»SoftBank to lead nearly $1.2 billion investment in diagnostics firm Invitae
    Investments

    SoftBank to lead nearly $1.2 billion investment in diagnostics firm Invitae

    April 6, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Invitae Corp said on Monday a group of investors including SoftBank Group Corp will invest $1.15 billion in the U.S. genetic diagnostics company. It said the investment, to be used for its growth initiatives, will be in convertible senior notes, which will bear 1.5% interest per year.

    The company said the notes will have an initial conversion price of $43.18 per share of its common stock, representing a premium of 10.2% to Invitae’s closing price on Friday. Earlier this year, SoftBank invested $900 million in gene sequencing firm Pacific Biosciences of California Inc.

    San Francisco-based Invitae offers genetic testing services for a range of diseases, including skin and eye conditions, cancers as well as reproductive health in and outside the United States. Shares of the company, which started operations in 2010, have more than tripled in the past twelve months, giving it a market valuation of $7.7 billion.

    J. Wood Capital Advisors LLC and Perella Weinberg Partners LP were financial advisers to Invitae on the transaction.

     

    Read More

    Source: Reuters

    Reporting by Amruta Khandekar in Bengaluru; Editing by Shinjini Ganguli

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital funds Investments Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    AXA, Unilever, and Tikehau Capital team up to launch EUR1 billion impact fund to accelerate regenerative agriculture transition

    May 19, 2022

    Zolar closes €100m Series C led by EIP and GIC

    May 19, 2022

    Woodside shareholders approve BHP petroleum merger

    May 19, 2022

    AGIC Capital Acquires a Majority Stake in Grafotronic

    May 19, 2022

    Comments are closed.

    Other Articles

    Rise in private equity allocations looks unstoppable, for now

    March 16, 2022

    Private Equity Women Investor Network appoints first Executive Director

    June 20, 2021

    Mainspring and Aspida launch USD550m Guernsey-domiciled private investment fund

    March 19, 2021

    Vital social care has become the plaything of the super-rich

    January 5, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?